Share of people with HIV who receive antiretroviral therapy in Togo
Togo: Share of people with HIV who receive antiretroviral therapy was 92.0% in 2024. ◆ Volatile
Share of people with HIV who receive antiretroviral therapy in Togo, 2000–2024
Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of people living with HIV.
Analysis
In 2024, share of people with hiv who receive antiretroviral therapy in Togo stood at 92.0%. That is the highest value across all 25 years on record.
The figure is up 5.7% on the previous year and up 148.6% over ten years.
Over the whole period, share of people with hiv who receive antiretroviral therapy in Togo peaked at 92.0% in 2024 and was at its lowest, 0.0%, in 2000.
Togo ranks 14th of 143 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Share of people with HIV who receive antiretroviral therapy in Togo, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 2.0% | +100.0% |
| 2005 | 5.0% | +150.0% |
| 2006 | 6.0% | +20.0% |
| 2007 | 7.0% | +16.7% |
| 2008 | 10.0% | +42.9% |
| 2009 | 15.0% | +50.0% |
| 2010 | 22.0% | +46.7% |
| 2011 | 27.0% | +22.7% |
| 2012 | 30.0% | +11.1% |
| 2013 | 34.0% | +13.3% |
| 2014 | 37.0% | +8.8% |
| 2015 | 44.0% | +18.9% |
| 2016 | 52.0% | +18.2% |
| 2017 | 60.0% | +15.4% |
| 2018 | 66.0% | +10.0% |
| 2019 | 76.0% | +15.2% |
| 2020 | 80.0% | +5.3% |
| 2021 | 81.0% | +1.2% |
| 2022 | 80.0% | -1.2% |
| 2023 | 87.0% | +8.8% |
| 2024 | 92.0% | +5.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.6% | 0.0% | 15.0% | 10 |
| 2010s | 44.8% | 22.0% | 76.0% | 10 |
| 2020s | 84.0% | 80.0% | 92.0% | 5 |
Countries ranked near Togo
More health data for Togo
- Un projection of annual infant deaths, annual growth rate -1.03 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7948 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 875 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,021 deaths (2100)
- Population ages 60-64, female, annual growth rate 3.04 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0103 units per person (2025)
- Population ages 60-64, male, annual growth rate 4.06 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.0092 units per person (2025)
Frequently asked questions
- What is share of people with hiv who receive antiretroviral therapy in Togo?
- Share of people with hiv who receive antiretroviral therapy in Togo was 92.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
- What is the highest share of people with hiv who receive antiretroviral therapy recorded in Togo?
- The highest recorded value was 92.0% in 2024.
- What is the lowest share of people with hiv who receive antiretroviral therapy recorded in Togo?
- The lowest recorded value was 0.0% in 2000.
- How does Togo rank for share of people with hiv who receive antiretroviral therapy?
- Togo ranks 14th out of 143 countries with data for 2024.
- Is share of people with hiv who receive antiretroviral therapy rising or falling in Togo?
- Over the last ten years it is up 148.6%. The long-run trend across the full record is volatile.
- Where does this Togo data come from?
- The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of people with HIV who receive antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.